Protara Therapeutics TARA
NASDAQ TARA
$3.94 -0.03 (-0.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) Acquisitions (2020)

Protara Therapeutics (TARA) posted quarterly Acquisitions of -$3.7 million for Q1 2020.

Analysis

Protara Therapeutics (TARA) Acquisitions (2020) Analysis & Trends

Protara Therapeutics (TARA) has reported Acquisitions for 1 consecutive years, with -$3.7 million the latest figure, recorded in Q1 2020.

  • In Q1 2020, Acquisitions changed N/A year-over-year to -$3.7 million; the TTM figure through Dec 2020 stood at -$3.7 million (changed N/A YoY), while the FY2020 annual figure was -$3.7 million, changed N/A from the prior year.
  • Acquisitions held at -$3.7 million in Q1 2020 per TARA's latest filing.
  • Across five years, Acquisitions topped out at -$3.7 million in Q1 2020 and bottomed at -$3.7 million in Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Protara Therapeutics 241.28 Mn 241.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -3.72 Mn